对于阿尔茨海默氏症的甲基1-42寡合体的跨膜结构
Birgit Strodel1, Jason W L Lee, Christopher S Whittleston
1Institut für Strukturbiologie und Biophysik, Strukturbiochemie, Forschungszentrum Jülich, 52425 Jülich, Germany. b.strodel@fz-juelich.de
Journal of the American Chemical Society
|September 9, 2010
概括
阿尔茨海默氏症的粉样β- (Aβ) 寡合体在膜中形成毛孔. 稳定的Aβ1-42) 结构表明四度和六度β片子单位可能会形成这些有毒的孔隙.
科学领域:
- 生物物理学的生物物理.
- 计算化学计算化学
- 神经科学是一个神经科学.
背景情况:
- 阿尔茨海默病与粉样β- (Aβ) 寡合体有关.
- 假设Aβ寡合体通过膜孔形成引起神经元毒性.
研究的目的:
- 在膜环境中建模Aβ(1-42) 寡合体.
- 阐明Aβ诱导的膜破坏和毒性的结构基础.
主要方法:
- 盆地跳跃结构识别的全球优化.
- 引入并行炼方案和寡合物生成程序.
- 在隐性脂质双层中建模Aβ{1-42}单体和小聚体 (高达八聚体).
主要成果:
- 确定了一种稳定的,覆盖膜的β片结构,用于Aβ(1-42) 单体.
- 观察到对二次体到六次体的有序β片结构.
- 发现八聚体在膜内分离成不同的稳定四聚体单元.
结论:
- 甲毛孔可能由四面体和六面体的甲板子单位组成.
- 拟议的Aβ毛孔模型与实验生物物理和生物化学数据一致.
- 提供了对阿尔茨海默氏症粉样蛋白毒性机制的结构性见解.
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...


